Overview of Basic Immunology for Clinical Investigators

被引:0
作者
Stephen, Bettzy [1 ]
Hajjar, Joud [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源
IMMUNOTHERAPY | 2017年 / 995卷
关键词
Adaptive; CTLA-4; Immune checkpoints; Tumor immunotherapy; Innate; PD-1; T cells; REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; MAST-CELLS; INNATE IMMUNITY; CANCER-IMMUNOTHERAPY; SIGNALING PATHWAYS; BREAST-CANCER; SUPPRESSOR-CELLS; HUMAN-ANTIBODIES; HUMAN BASOPHILS;
D O I
10.1007/978-3-319-53156-4_1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells are found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and the cross talk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter, we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.
引用
收藏
页码:1 / 31
页数:31
相关论文
共 192 条
  • [1] A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
    Acharyya, Swarnali
    Oskarsson, Thordur
    Vanharanta, Sakari
    Malladi, Srinivas
    Kim, Juliet
    Morris, Patrick G.
    Manova-Todorova, Katia
    Leversha, Margaret
    Hogg, Nancy
    Seshan, Venkatraman E.
    Norton, Larry
    Brogi, Edi
    Massague, Joan
    [J]. CELL, 2012, 150 (01) : 165 - 178
  • [2] NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
    Albertsson, PA
    Basse, PH
    Hokland, M
    Goldfarb, RH
    Nagelkerke, JF
    Nannmark, U
    Kuppen, PJK
    [J]. TRENDS IN IMMUNOLOGY, 2003, 24 (11) : 603 - 609
  • [3] [Anonymous], 2016, HEM ONC CANC APPR SA
  • [4] [Anonymous], FDA APPR KEYTR ADV N
  • [5] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
    Ansell, Stephen M.
    Lesokhin, Alexander M.
    Borrello, Ivan
    Halwani, Ahmad
    Scott, Emma C.
    Gutierrez, Martin
    Schuster, Stephen J.
    Millenson, Michael M.
    Cattry, Deepika
    Freeman, Gordon J.
    Rodig, Scott J.
    Chapuy, Bjoern
    Ligon, Azra H.
    Zhu, Lili
    Grosso, Joseph F.
    Kim, Su Young
    Timmerman, John M.
    Shipp, Margaret A.
    Armand, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) : 311 - 319
  • [6] Rationale for anti-OX40 cancer immunotherapy
    Aspeslagh, Sandrine
    Postel-Vinay, Sophie
    Rusakiewicz, Sylvie
    Soria, Jean-Charles
    Zitvogel, Laurence
    Marabelle, Aurelien
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 52 : 50 - 66
  • [7] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [8] Natural killer cells in innate immunity and cancer
    Becknell, Brian
    Caligiuri, Michael A.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (08) : 685 - 692
  • [9] The new deal a potentia role for secretec vesicles in innate immunity and tumor progression
    Benito-Martin, Alberto
    Di Giannatale, Angela
    Ceder, Sophia
    Peinado, Hector
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 13
  • [10] Developing a new paradigm for thymus organogenesis
    Blackburn, CC
    Manley, NR
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (04) : 278 - 289